| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 7,570,000 | 8,712,000 | 9,275,000 | 9,674,000 | | Cost of Revenue | 5,756,000 | 6,523,000 | 7,476,000 | 7,323,000 | | | Gross Profit | 1,814,000 | 2,189,000 | 1,799,000 | 2,351,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,152,000 | 1,179,000 | 1,309,000 | 1,290,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 662,000 | 1,010,000 | 490,000 | 1,061,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,000) | (2,000) | 629,000 | 32,000 | | Earnings Before Interest And Taxes | 660,000 | 1,022,000 | 1,146,000 | 1,099,000 | | Interest Expense | 117,000 | 114,000 | 112,000 | 115,000 | | Income Before Tax | 543,000 | 908,000 | 1,034,000 | 984,000 | | Income Tax Expense | 144,000 | 201,000 | 315,000 | 261,000 | | Minority Interest | (2,000) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 397,000 | 707,000 | 719,000 | 723,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 397,000 | 707,000 | 719,000 | 723,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $397,000 | $707,000 | $719,000 | $723,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
